NCT05309720

Brief Summary

The standard treatment of deep dermal to full thickness burns is surgical removal of the burn followed by skin transplantation. Dermal substitutes are increasingly used in the treatment of deep burns to replace lost dermis. Preservation of the collagen and elastin in the acellular human dermal substitute Glyaderm provides a more elastic scar. It is unknown what the effect of Glyaderm on scar quality is in a solely paediatric population. The objective of this case series is to investigate scar maturation and scar quality when applying Glyaderm in deep dermal to full thickness burns in a pediatric population aged ≤15 years old.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 4, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

April 12, 2024

Status Verified

November 1, 2023

Enrollment Period

3.2 years

First QC Date

March 15, 2022

Last Update Submit

April 10, 2024

Conditions

Keywords

BurnsScar qualityPediatric

Outcome Measures

Primary Outcomes (1)

  • Scar quality (clinician)

    Scar quality measured using the Patient and Observer Scar Assessment Scale (POSAS) Observer Scale, which rates the scar from 1 (=like normal skin) to 10 (=worst scar imaginable).

    12 months

Secondary Outcomes (9)

  • Clinical assessment of the graft take

    5-7 days after STSG application

  • Wound epithelialization

    5-7 days after STSG application

  • Wound healing time

    determined in the first several days to weeks after STSG application

  • Donor site healing time

    determined in the first several days to weeks after STSG application

  • Scar surface area

    day of surgery (day 0) and 3, 6 and 12 months post-surgery

  • +4 more secondary outcomes

Study Arms (1)

Glyaderm

EXPERIMENTAL
Procedure: Glyaderm

Interventions

GlyadermPROCEDURE

All included patients will undergo full thickness removal of the burned skin or adequate debridement of all necrotic tissue. Next, the dermal substitute Glyaderm followed by a split thickness skin graft will be transplanted on the wound.

Glyaderm

Eligibility Criteria

AgeUp to 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age ≤15 years old
  • Burn wounds requiring skin grafting
  • Written informed consent provided by
  • The participant's parent(s)/guardian (\<12 years of age)
  • The participant's parent(s)/guardian and the participant itself (12-15 years old)

You may not qualify if:

  • Burn wound of ≤30 cm2
  • Infected burn wounds: clinical symptoms in combination with positive wound swabs
  • Patients/parents with insufficient knowledge of the Dutch or English language, since they would not be able to complete the POSAS questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboudumc

Nijmegen, Netherlands

RECRUITING

MeSH Terms

Conditions

Burns

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Marielle Vehmeijer-Heeman, MD, PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: prospective case series
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2022

First Posted

April 4, 2022

Study Start

September 1, 2022

Primary Completion

November 1, 2025

Study Completion

November 1, 2025

Last Updated

April 12, 2024

Record last verified: 2023-11

Locations